Protagonist Therapeutics
PTGX
PTGX
273 hedge funds and large institutions have $4.7B invested in Protagonist Therapeutics in 2025 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 84 increasing their positions, 109 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.9% less ownership
Funds ownership: 114.51% → 113.62% (-0.9%)
23% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 109
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
Holders
273
Holding in Top 10
10
Calls
$12.2M
Puts
$3.45M
Top Buyers
| 1 | +$72.1M | |
| 2 | +$57.8M | |
| 3 | +$43.5M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$32.6M |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$29.8M |
Top Sellers
| 1 | -$102M | |
| 2 | -$43.2M | |
| 3 | -$40.2M | |
| 4 |
Holocene Advisors
New York
|
-$29.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$24.8M |
